0001209191-23-016688.txt : 20230307 0001209191-23-016688.hdr.sgml : 20230307 20230307160411 ACCESSION NUMBER: 0001209191-23-016688 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dethlefs Sven CENTRAL INDEX KEY: 0001726010 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16174 FILM NUMBER: 23712531 MAIL ADDRESS: STREET 1: 5 BASEL STREET, P.O. BOX 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 4951033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000818686 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 BAZEL ST STREET 2: P O B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 BUSINESS PHONE: 9729267267 MAIL ADDRESS: STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED STREET 2: 5 BAZEL ST PO B 3190 CITY: PETACH TIKVA STATE: L3 ZIP: 49131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-03 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001726010 Dethlefs Sven C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 EVP, North America Commercial Ordinary Shares 2023-03-04 4 M 0 13931 A 179312 D Ordinary Shares 2023-03-04 4 M 0 38538 A 217850 D Ordinary Shares 2023-03-05 4 M 0 24952 A 242802 D Restricted Share Units 2023-03-03 4 A 0 99601 0.00 A Ordinary Shares 99601 99601 D Restricted Share Units 2023-03-04 4 M 0 13931 0.00 D Ordinary Shares 13931 0 D Restricted Share Units 2023-03-04 4 M 0 38538 0.00 D Ordinary Shares 38538 115617 D Restricted Share Units 2023-03-05 4 M 0 24952 0.00 D Ordinary Shares 24952 49905 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027. Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023. Restricted share units were granted on March 4, 2022, with 33,538 vested on March 4, 2023, 33,538 vesting on each of March 4, 2024 and March 4, 2025, and 38,541 vesting on March 4, 2026. Restricted share units were granted on March 5, 2021, with 24,952 vested on each of March 5, 2022, March 5, 2023 and March 5, 2024, and 24,953 vesting on March 5, 2025. /s/ Dov Bergwerk as attorney-in-fact for Sven Dethlefs 2023-03-07